Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases

Dear Colleagues,

A new program solicitation (RFA-AI-21-021) is now available:

Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)

Please see  https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-021.html for details.

Earliest submission date: June 02, 2021 following standard due date outlined in the FOA until July 07, 2023.

For timely responses to your questions, please direct your email messages to:

AI-DSFOAinquiries@nih.gov

-------------------------------------------------------------

From the Program Solicitation:

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the enhancement and/or sustainment of high-value data science research software to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge across the immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation.

 

As a part of the trans-NIAID data science program, this FOA focuses on enhancement and/or sustaining operations and improving the user experience and availability of existing, widely adopted informatics tools and resources. This contrasts with exploratory (R21) and early-stage (U01) development efforts to generate these tools and resources that are supported by the companion FOAs.

Estimated Number of Awards:  NIAID intends to commit $1,800,000 in FY 2022 to fund up to 2 awards.

Activity Code (e.g., RO1, U01)
U24
Funding Announcement Number
RFA-AI-21-021
Posted Date
Expiration Date
Application Due Date <br> (You may list multiple Application Due Dates)
Participating Organizations
Table sorting checkbox
Off